Clinical Outcomes in Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Infection: A Cohort Study
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiaf460 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Ya Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Klebsiella Infections, Klebsiella pneumoniae, Carbapenem-Resistant Enterobacteriaceae. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Klebsiella pneumoniae is a major pathogen with carbapenem resistance and hypervirulence as common evolutional pathways leading to poor outcomes. Hypervirulent carbapenem-resistant K. pneumoniae (hvCRKP) has emerged, typically via acquisition of virulence plasmids encoding hypervirulence factors by CRKP. However, whether hypervirulence worsens patient outcomes in the setting of carbapenem resistance remains unclear.
Methods
We conducted an observational cohort study comprising 3-year (2019–2022) data in a Chinese university hospital. We performed genome sequencing for CRKP strains, compared adult patients infected by hvCRKP with those infected by nonhypervirulent “classic” CRKP (cCRKP), and used propensity score matching for imbalanced baseline characteristics. We defined 30-day all-cause and attributed mortality rates and 30-day ranking outcomes (death, no response/progress, or remission) as primary outcomes and postinfection stay and survival as secondary outcomes.
Results
Patients with hvCRKP (n = 262) or cCRKP (n = 294) infection had similar 30-day mortality rates (all-cause, 30.9% vs 33.7% [P = .49]; infection attributed, 24.4% vs 26.2%b [P = .77]), no response/progress rate (19.8% vs 20.4%; P = .72), postinfection hospital stay (median, 13 vs 15 days; P = .19), and postinfection survival (median, 18.5 vs 24.5 days; P = .22). All outcomes were also similar (P > .05) between the 2 groups after propensity score matching and in all subgroup analyses.
Conclusions
The hypervirulence of K. pneumoniae remains not well defined. The concept of hvCRKP in current form should not be overemphasized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
- Center for Pathogen Research, West China Hospital, Sichuan University, Chengdu, China.
- General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China.
- Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, China.
- Intensive Care Unit, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Ya Hu, Yu Feng, Zhiyong Zong
Zitieren
APA
Hu, Y., Fang, Q., Zhang, L., He, Y., Feng, Y., Yang, J., & Zong, Z. (2026). Clinical Outcomes in Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Infection: A Cohort Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf460
Vancouver
Hu Y, Fang Q, Zhang L, He Y, Feng Y, Yang J, et al. Clinical Outcomes in Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Infection: A Cohort Study. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf460
BibTeX
@article{Hu2026,
author = {Hu, Ya and Fang, Qingqing and Zhang, Linwan and He, Yanling and Feng, Yu and Yang, Jing and Zong, Zhiyong},
title = {Clinical Outcomes in Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Infection: A Cohort Study},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiaf460}
}
EUVIMED